“VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products.
Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunisa.tion (AEFIs) – are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring (PIDM).
WHO PIDM was created in 1968 to ensure the safer and more effective use of medicinal products.”
Source: www.vigiaccess.org
